1 / 6

Microcarriers Market

Microcarriers Market Size Worth USD 5,230.23 Million by 2034 | CAGR: 10.4%

Emma279
Télécharger la présentation

Microcarriers Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Microcarriers Market Microcarriers Market Size Worth USD 5,230.23 Million by 2034 | CAGR: 10.4% Microcarriers Market Size, Share, Trends, Industry Analysis Report: By Product (Consumables and Equipment), Application, Therapy, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034

  2. Microcarriers Market • The microcarriers market size was valued at USD 1,949.02 million in 2024. The market is projected to grow from US 2,146.85 million in 2025 to USD 5,230.23 million by 2034, exhibiting a CAGR of 10.4% during 2025–2034. Request To Sample : https://www.polarismarketresearch.com/industry-analysis/microcarriers-market/request-for-sample

  3. Microcarriers Market • Key Market Players : • BD • Bio-Rad Laboratories, Inc. • Corning Incorporated • denovoMATRIX GmbH • Eppendorf SE • FUJIFILM Holdings Corporation • HiMedia Laboratories Pvt. Ltd. • Lonza Group Ltd. • Merck KGaA • Sartorius AG • Thermo Fisher Scientific Inc.

  4. Microcarriers Market Microcarriers Market Report Highlights • By application, biopharmaceutical production held the largest microcarriers market share in 2024, primarily due to the increasing demand for vaccines, monoclonal antibodies, and cell-based therapies. The need for scalable and efficient cell expansion technologies in biologics manufacturing reinforces the segment’s dominance. • By therapy, the cell & gene therapy segment held the highest market share in 2024, driven by advancements in regenerative medicine and growing regulatory approvals for innovative cell-based treatments. The rising investment in cell therapy research and manufacturing capacity expansions further support this segment’s leadership. • North America held the largest market share in 2024, primarily due to its robust biopharmaceutical industry and substantial investments in cell and gene therapy research. Buy Now :https://www.polarismarketresearch.com/buy/3398/0

  5. 𝐀𝐛𝐨𝐮𝐭 𝐔𝐬: Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. 𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗜𝗻𝗳𝗼:Polaris Market ResearchPhone: +1-929-297-9727Email: sales@polarismarketresearch.com

More Related